Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Pulmonary/Respiratory Diseases | Family Medicine
 Disease Category: Congestive Heart Failure
Location: United States, FL

Trial Information

Are you undergoing treatment for Congestive Heart Failure?

Patients may be entered in the study who are>18 years of age with at least a 30-day history of NYHA Class II to IV HF and and any documented left ventricular ejection fraction within a year prior to screening and signs of volume overload.

Patient Inclusion Criteria:

  • History of chronic CHF requiring standard HF treatment including diuretics for a minimum of 30 days.

Patient Exclusion Criteria:

  • Heart attack or stroke within 30 days prior to screening.
  • Clinically significant valvular disease

Karen Renaud, Study Coordinator
Tampa Clinical Research
4290 W. Linebaugh Avenue
Tampa, FL 33624
Phone: 813-960-7070
Fax: 813-960-7979
Email: krenaud@tampaclinicalresearch.com

View Map

Research Center Information: Tampa Clinical Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.